Aspira Women's Health Inc.

AWHL Healthcare Diagnostics & Research

In the quarter to June 2026, revenue fell 14.9%, EPS grew 28.6%, free cash flow fell 24.6% and total debt rose 25.9%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for five, operating cash flow growth for three; insiders bought in the last twelve months.

0.23 0.02 −8.00%
Market cap
$2.4M
P/E
0.0×
Fwd P/E
−0.6×
Dividend yield
—
F-score
5/9
Altman Z
−141.56
Beneish M
−7.05
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

6 5 3 2
ROE
314.66% 269.20% 327.14% 201.29%
ROA
(179.16%) (233.49%) (173.69%) (213.58%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(646.65%) (1,981.40%) 578.50% 423.40%
Average Days of Receivables
51.48 47.80 58.37 63.42
Free Cash Flow per Share
(0.17) (0.21) (0.10) (0.11)
Free Cash Flow
(6.09) (7.05) (4.29) (4.73)
Other line items

Show all line items

Columns are period end dates